Interactive Biosoftware Sophia Genetics Acquires Interactive Biosoftware Premium With its purchase of decision support technology maker Interactive Biosoftware, Sophia looks to extend its AI platform deeper into NGS interpretation. Centogene Signs Collaboration Agreement With Interactive Biosoftware The two companies plan to join their respective technologies in order to help clinicians better interpret genetic variant data. Interactive Biosoftware, Genohm Ink Software Integration Agreement The combined products will provide customers with a comprehensive solution for managing next-generation sequencing workflows in the lab. Ranomics Touts Functional Genomics Studies as Solution to Genetic Testing Market's VUS Challenge Premium Ranomics is building a business around providing functional data on variants of unknown significance, starting with BRCA1 mutations. Downloads and Upgrades: Alamut-HT 1.1, Ingenuity Systems Premium This week, Interactive Biosoftware released Alamut-HT 1.1, an upgraded version of its genomic variant annotation and interpretation software. Nov 9, 2012 Cartagenia, Interactive Biosoftware Enter Software Integration Agreement Premium Nov 6, 2012 Cartagenia, Interactive Biosoftware to Integrate Genomic Variation Data Tools Jun 20, 2012 New Products: Illumina's RapidTrack WGS Service; Interactive Biosoftware's Alamut Premium Apr 6, 2012 Interactive Biosoftware Adds High-Throughput Variant Annotation Software to Portfolio Premium Mar 4, 2011 French Informatics Firm Touts 'Mutation Interpretation' as Key Differentiator of its Data-Analysis Software Premium Breaking News Rare Kidney Cancer Genomic Analysis Reveals Potential Target, Suggests Treatment SEC Concludes CareDx Investigation, Recommends No Enforcement Action Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance Adela Closes $48M Financing to Develop Cancer Monitoring, Early Detection Test 3EO Health At-Home Molecular COVID-19 Test Nabs FDA EUA The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.